160 related articles for article (PubMed ID: 29504965)
1. Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes.
Beaufils E; Vercouillie J; Vierron E; Cottier JP; Camus V; Mondon K; Guilloteau D; Hommet C; Ribeiro MJ
Clin Nucl Med; 2018 Apr; 43(4):e103-e108. PubMed ID: 29504965
[TBL] [Abstract][Full Text] [Related]
2. Dual-phase
Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
[TBL] [Abstract][Full Text] [Related]
3. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.
Santos-Santos MA; Rabinovici GD; Iaccarino L; Ayakta N; Tammewar G; Lobach I; Henry ML; Hubbard I; Mandelli ML; Spinelli E; Miller ZA; Pressman PS; O'Neil JP; Ghosh P; Lazaris A; Meyer M; Watson C; Yoon SJ; Rosen HJ; Grinberg L; Seeley WW; Miller BL; Jagust WJ; Gorno-Tempini ML
JAMA Neurol; 2018 Mar; 75(3):342-352. PubMed ID: 29309493
[TBL] [Abstract][Full Text] [Related]
4. Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.
Villarejo-Galende A; Llamas-Velasco S; Gómez-Grande A; Puertas-Martín V; Contador I; Sarandeses P; González-Sánchez M; Trincado R; Pilkington P; Ruiz-Solis S; Pérez-Martínez DA; Herrero-San Martín A
J Neurol; 2017 Jan; 264(1):121-130. PubMed ID: 27815682
[TBL] [Abstract][Full Text] [Related]
5. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
[TBL] [Abstract][Full Text] [Related]
6. Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis.
Perini G; Cotta Ramusino M; Sinforiani E; Franciotta D; Trifirò G; Ceroni M; Costa A
Alzheimer Dis Assoc Disord; 2019; 33(3):282-284. PubMed ID: 30640253
[TBL] [Abstract][Full Text] [Related]
7. Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology.
Martersteck A; Ayala I; Ohm DT; Spencer C; Coventry C; Weintraub S; Bigio EH; Mesulam M-; Geula C; Rogalski E
Acta Neuropathol Commun; 2022 Aug; 10(1):111. PubMed ID: 35945628
[TBL] [Abstract][Full Text] [Related]
8. Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia.
Schaeverbeke J; Gabel S; Meersmans K; Bruffaerts R; Liuzzi AG; Evenepoel C; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
Alzheimers Res Ther; 2018 Jul; 10(1):68. PubMed ID: 30021613
[TBL] [Abstract][Full Text] [Related]
9. Is in vivo amyloid distribution asymmetric in primary progressive aphasia?
Martersteck A; Murphy C; Rademaker A; Wieneke C; Weintraub S; Chen K; Mesulam MM; Rogalski E;
Ann Neurol; 2016 Mar; 79(3):496-501. PubMed ID: 26600088
[TBL] [Abstract][Full Text] [Related]
10. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.
Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD
J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898
[TBL] [Abstract][Full Text] [Related]
11. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
12. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
13. Distinct [
Schaeverbeke J; Evenepoel C; Declercq L; Gabel S; Meersmans K; Bruffaerts R; Adamczuk K; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2342-2357. PubMed ID: 29946950
[TBL] [Abstract][Full Text] [Related]
14. Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.
Ramanan S; Flanagan E; Leyton CE; Villemagne VL; Rowe CC; Hodges JR; Hornberger M
J Alzheimers Dis; 2016; 51(2):367-76. PubMed ID: 26890745
[TBL] [Abstract][Full Text] [Related]
15. Imaging characteristics and safety of florbetapir (¹⁸F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer's disease.
Namiki C; Takita Y; Iwata A; Momose T; Senda M; Okubo Y; Joshi AD; Lu M; Agbulos A; Breault C; Pontecorvo MJ
Ann Nucl Med; 2015 Aug; 29(7):570-81. PubMed ID: 25943346
[TBL] [Abstract][Full Text] [Related]
16. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
[TBL] [Abstract][Full Text] [Related]
17. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.
Louwersheimer E; Keulen MA; Steenwijk MD; Wattjes MP; Jiskoot LC; Vrenken H; Teunissen CE; van Berckel BN; van der Flier WM; Scheltens P; van Swieten JC; Pijnenburg YA
J Alzheimers Dis; 2016; 51(2):581-90. PubMed ID: 26890751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]